Cargando…
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer
PURPOSE: Circulating miRNAs can provide valid prognostic and predictive information for breast cancer diagnosis and subsequent management. They may comprise quintessential biomarkers that can be obtained minimally invasively from liquid biopsy in metastatic breast cancer patients. Therefore, they wo...
Autores principales: | Fischer, Chiara, Deutsch, Thomas M., Feisst, Manuel, Rippinger, Nathalie, Riedel, Fabian, Hartkopf, Andreas D., Brucker, Sara Y., Domschke, Christoph, Fremd, Carlo, Michel, Laura, Burwinkel, Barbara, Schneeweiss, Andreas, Turchinovich, Andrey, Wallwiener, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411224/ https://www.ncbi.nlm.nih.gov/pubmed/35237856 http://dx.doi.org/10.1007/s00404-022-06442-2 |
Ejemplares similares
-
Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment
por: Fischer, Chiara, et al.
Publicado: (2022) -
Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020) -
How previous treatment changes the metabolomic profile in patients with metastatic breast cancer
por: Nees, Juliane, et al.
Publicado: (2022) -
HER2-targeted therapy influences CTC status in metastatic breast cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020) -
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer
por: von Au, Alexandra, et al.
Publicado: (2022)